IP Library Granted Patent US 9,427,417
Granted Patent B2
US 9,427,417 · App. 15/075,147 · Granted Aug 30, 2016

Wound treatment employing antimicrobial composition

Inventor: Matthew Franco Myntti (St. Augustine, FL)
Assignee: Next Science, LLC
A61K31/14A61K47/12A61K47/34
View Patent ↗
Loading inventors, assignments & file history…
Monitor This Case
Get email alerts when status or documents change.
Order Certified Copies
Most orders are placed with the USPTO same day — all within 24 business hours.
Order via The Patent Place →
Pre-filled with this patent's details
Quick Facts
Patent No.
US 9,427,417
App. No.
15/075,147
Granted
Aug 30, 2016
Kind
B2
Abstract

A process for reducing bacterial colonization in or around the area of a wound includes applying to the area a gel that includes at least one PEG and an aqueous composition which has a pH of from 2 to 4, a total solute concentration of from 1.8 to 4.0 Osm/L, and from 0.9 to 1.7 g/L of at least one cationic surfactant. The aqueous composition can include a buffer system that includes an organic acid and a salt of an organic acid. The gel is effective even when free of materials having antimicrobial properties other than those provided by the aqueous composition, such as sporicides, antifungals and antibiotics.

Claims (26)

1. A process for reducing bacterial colonization in or around the area of a wound, said process comprising applying to said area a gel that comprises at least one PEG and an aqueous composition having a pH of from 2 to 4, a total solute concentration of from 1.8 to 4.0 Osm/L, and from 0.9 to 1.7 g/L of at least one cationic surfactant, said gel being free of sporicides, antifungals and antibiotics.

2. The process of claim 1 wherein said aqueous composition has a total solute concentration of from 1.8 to 2.8 Osm/L.

3. The process of claim 1 wherein said at least one cationic surfactant comprises benzalkonium chloride.

4. The process of claim 1 wherein said at least one cationic surfactant is benzalkonium chloride.

5. A process for reducing bacterial colonization in or around the area of a wound, said process comprising applying to said area a gel that consists essentially of at least one PEG, an aqueous composition having a pH of from 2 to 4, a total solute concentration of from 1.8 to 4.0 Osm/L, and from 0.9 to 1.7 g/L of at least one cationic surfactant, and optionally one or more of an emollient, a lotion, a humectant, a glycosaminoglycan, an analgesic, colloidal silver and a coalescent.

6. The process of claim 5 wherein said aqueous composition has a total solute concentration of from 1.8 to 2.8 Osm/L.

7. The process of claim 5 wherein said at least one cationic surfactant comprises benzalkonium chloride.

8. The process of claim 5 wherein said at least one cationic surfactant is benzalkonium chloride.

9. A process for reducing bacterial colonization in or around the area of a wound, said process comprising applying to said area a gel that comprises

a) at least one PEG and

b) a composition having a pH of from 2 to 4 and a total solute concentration of from 1.8 to 4.0 Osm/L that consists essentially of

(1) water,

(2) a buffer system that comprises of one or more organic acids and at least one salt of one or more organic acids, and

(3) from 0.9 to 1.7 g/L of at least one cationic surfactant,

said gel being free of materials having antimicrobial properties other than those provided by said composition.

10. The process of claim 9 wherein said composition has a total solute concentration of from 1.8 to 2.8 Osm/L.

11. The process of claim 9 wherein said at least one cationic surfactant comprises benzalkonium chloride.

12. The process of claim 9 wherein said at least one cationic surfactant is benzalkonium chloride.

13. The process of claim 9 wherein said one or more organic acids comprise at least one polyacid.

14. The process of claim 13 wherein said at least one polyacid comprises citric acid.

15. The process of claim 14 wherein said at least one salt of one or more organic acids comprises a salt of a polyacid.

16. The process of claim 9 wherein each of said one or more organic acids is a polyacid.

17. The process of claim 9 wherein said one or more organic acids is citric acid.

18. The process of claim 17 wherein said at least one salt comprises a salt of citric acid.

19. The process of claim 9 wherein said at least one salt is a salt of citric acid.

20. The process of claim 9 wherein said one or more organic acids is acetic acid.

Assignments (2)
ASSIGNMENT OF ASSIGNOR'S INTEREST Recorded Oct 19, 2025
From: NEXT SCIENCE IP HOLDINGS PTY LTD
To: OSARTIS GMBH
Reel/Frame 072590/0763 →
NUNC PRO TUNC ASSIGNMENT Recorded Mar 24, 2018
From: NEXT SCIENCE, LLC
To: NEXT SCIENCE IP HOLDINGS PTY LTD
Reel/Frame 045344/0297 →
Continuity (5)
Continuation 13684456 · Nov 23, 2012
Continuation PCTUS2012059263 · Oct 8, 2012
Provisional Application 61545108 · Oct 8, 2011
Provisional Application 61660649 · Jun 15, 2012
Related Publication 20160199322A1 · Jul 14, 2016